Skip to content
Home/Companies/Biotech/Meiogenix
ME

Meiogenix

Biotech·France·Active·7yr hold

Meiogenix is a healthcare company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Meiogenix?

Meiogenix is currently owned by Sofinnova Partners through Sofinnova Industrial Biotech (2018 vintage), since 2019. Across its history, Meiogenix has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Kurma Partners and Sofinnova Partners since 2019.
Co-invest · 2 holders · 2019 · present
Kurma Partners
Kurma PartnersActive
2019 · present · Kurma Biofund I · 2009 · VC
MOIC
–
Sofinnova Partners
Sofinnova PartnersActive
2019 · present · Sofinnova Industrial Biotech · 2018 · VC
MOIC
–

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

Arzeda
Active
BiotechUS· 2022
IB WORKS I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Active
BiotechSpain· 2021
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings